水友性奇托桑/石墨烯氧化物复合海绵用于快速静血和非再出血的去除
Fanglin Du1, Wenjing A1, Fang Liu2
1State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, PR China.
Carbohydrate polymers
|June 15, 2023
概括
一种新的素/石墨烯氧化物复合海绵 (CSAG) 提供了有效的创伤出血控制,显著减少了组织粘附. 这种创新的静血材料可以防止在切除后再次出血,从而改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 材料工程 材料工程 材料工程
背景情况:
- 水友性静血海绵对于创伤出血控制至关重要.
- 当前海绵的强大的组织粘附导致伤口并发症,如撕裂和重新出血.
研究的目的:
- 开发一种水友性,抗粘合性奇多/石墨烯氧化物复合海绵 (CSAG).
- 为了评估CSAG的静血效果,机械性能和组织粘附.
- 为了研究CSAG在没有再出血的情况下容易去除的机制.
主要方法:
- 制造一种基多/石墨烯氧化物复合海绵 (CSAG).
- 评估机械强度和液体吸收.
- 在体内评估严重出血模型中的静血性能.
- 测量剥离力以量化组织粘附.
主要成果:
- 与商业血静止剂相比,CSAG在体内表现出优越的血静止性能.
- 与商业布相比,CSAG的组织粘附度显著降低,剥离力减少了79.3%.
- 在CSAG-伤口界面的气泡/腔隙促进了容易去除和部分血脱落,防止再出血.
结论:
- CSAG是一种高效的静血材料,具有较低的组织粘附性.
- CSAG的抗粘性和独特的去除机制为创伤护理提供了显著的进步.
- 这项研究提出了一种用于设计先进抗粘性静血材料的新方法.
关键词:
氨基硫酸盐 (PubChem CID: 62648) 的使用情况抗粘附,可以防止粘附.奇托 (PubChem CID: 71853) 是一种化学物质.石墨烯氧化物 石墨烯氧化物石墨粉末 (PubChem CID: 5462310) 的使用情况盐酸 (PubChem CID: 313) 的使用情况过氧化 (PubChem CID: 784) 是一种水友性静血海绵是一种水友性静血海绵.甲基烯酸化物 (PubChem CID: 12974) 是一种N,N′-甲二甲胺 (PubChem CID: 8041) 是一种基胺.没有再出血的去除.甲酸 (PubChem CID: 516875) 是一种酸.快速的血液静止 迅速的血液静止酸 (PubChem CID: 24268) 是一种酸盐.硫酸 (PubChem CID: 1118) 的使用情况相关概念视频
Introduction to Hemostasis
8.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
767
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767


